Skip to main content
Press release September 28, 2026

AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026

Angiodynamics Inc (ANGO)

LATHAM, N.Y. --(BUSINESS WIRE)--Sep. 28, 2026-- AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report
View original release